GleamWall
中文EN

COCH Envoy Medical, Inc.

Orthopedic, Prosthetic & Surgical Appliances & Supplies · Nasdaq · SEC CIK 1840877 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY11.1%
TTM net income YoY4.3%
TTM EPS YoY164.4%
Revenue 3-yr CAGR-1.4%
Net income 3-yr CAGR—

Margins

Gross margin-352.8%
Operating margin-10,151.5%
Net margin-9,026.4%
FCF margin—
EBITDA margin-10,020.8%

Returns

ROE—
ROA-152.5%
ROIC (approx.)—
Asset turnover0.02x

Leverage & solvency

Liabilities / assets106.0%
Debt / equity—
Current ratio1.21x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.07x
Accruals ratio10.1%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$66,000$51,000$39,000$75,000$42,000$78,000$46,000$42,000
Cost of revenue$244,000$278,000$313,000$211,000$203,000$234,000$226,000$157,000
Gross profit-$178,000-$227,000-$274,000-$136,000-$161,000-$156,000-$180,000-$115,000
R&D expense$3.08M$3.13M$3.64M$4.55M$2.70M$2.48M$2.75M$2.47M
SG&A expense$2.12M$2.03M$1.88M$1.60M$2.00M$2.07M$1.82M$1.42M
Operating income-$5.54M-$5.57M-$5.96M-$6.38M-$5.26M-$5.07M-$5.11M-$4.52M
Interest expense———$0$471,000$624,000$495,000$384,000
Net income-$3.93M-$5.98M-$4.35M-$6.59M-$6.48M-$5.69M-$5.00M-$4.62M
EBITDA-$5.46M-$5.50M-$5.89M-$6.30M-$5.19M-$4.99M-$5.05M-$4.48M
EPS (basic)-0.50-0.07-0.08—-3.55-0.32-0.29—
EPS (diluted)-0.50-0.07-0.08—-3.55-0.32-0.29—
Weighted avg. shares (diluted)10.43M104.04M68.93M—2.19M21.38M21.33M—
Balance sheet
Cash & equivalents$14.57M$19.68M$25.25M$3.74M$3.56M$5.29M$5.31M$5.48M
Receivables$51,000$49,000$31,000$34,000$35,000$43,000$42,000$38,000
Inventory$1.51M$1.58M$1.49M$1.55M$1.64M$1.59M$1.66M$1.71M
Current assets$17.26M$21.92M$27.68M$6.28M$5.76M$7.51M$8.31M$8.90M
PP&E, net$854,000$921,000$962,000$1.03M$1.12M$1.14M$1.22M$1.27M
Total assets$19.16M$23.95M$29.82M$8.56M$8.18M$9.90M$10.38M$11.54M
Current liabilities$14.27M$12.63M$12.21M$11.56M$8.99M$8.00M$7.59M$7.54M
Total liabilities$20.30M$20.25M$19.27M$20.32M$15.71M$39.76M$34.61M$30.38M
Shareholders' equity-$1.53M$3.30M$10.16M-$12.16M-$7.66M-$29.86M-$24.22M-$18.84M
Shares outstanding—————21.52M21.33M21.33M
Cash flow statement
Operating cash flow-$5.03M-$5.46M-$6.06M-$5.68M-$4.33M-$4.46M-$3.73M-$4.39M
Capital expenditure$27,000——$172,000$0$1,000$6,000-$534,000
Free cash flow-$5.06M——-$5.86M-$4.33M-$4.46M-$3.73M-$3.85M
Investing cash flow-$27,000——-$172,000$0-$1,000-$6,000$534,000
Financing cash flow-$51,000-$109,000$27.57M$6.04M$2.60M$4.44M$3.55M$4.91M
Depreciation & amortization$75,000$74,000$73,000$80,000$76,000$85,000$61,000$48,000
Stock-based compensation$307,000$214,000$239,000$179,000$172,000$146,000$160,000$153,000
Dividends paid———-$1,000$0$607,000$1.21M$614,000

Free plan shows the latest 8 periods; Pro shows all 23 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.